Literature DB >> 23817952

Peripherally inserted central venous catheters in critically ill premature neonates.

Servet Ozkiraz1, Zeynel Gokmen, Deniz Anuk Ince, Abdullah Baris Akcan, Hasan Kilicdag, Deniz Ozel, Ayse Ecevit.   

Abstract

PURPOSE: To evaluate the safety of peripherally inserted central venous catheters (PICCs) and their complications in critically ill premature neonates.
METHODS: A retrospective collection of data of infants with very low birth weight (VLBW) who underwent PICC placement over a 2-year period. Gestational age, birth weight (BW), sex, site of catheter placement, reason for catheter removal, duration of the catheter use, proven sepsis, type of the reported organism and the rate of complications were collected. The infants were classified into two groups according to BWs: Group 1-VLBW infants (BW between 1,000 and 1,500 g) and Group 2-BW <1,000 g (extremely low birth weight, ELBW group).
RESULTS: During the study period, 90 VLBW infants were admitted to the neonatal intensive care unit. PICCs were attempted in 71 patients. A PICC was successfully inserted into 62 patients (87.3%). Totally, 68 PICCs were inserted into 62 infants. PICCs placed in either the upper or the lower extremity have no differences in complication rates. The median time of catheter insertion was 10 (1-22) days for Group 1 and 16 (1-47) days for Group 2 (p=0.001). The median duration of PICCs was 9 (2-18) and 12.0 (3-30) days, respectively (p=0.012). There were no significant differences between groups for the reasons for removal (p=0.859).
CONCLUSIONS: PICCs are convenient for the administration of long course antibiotics and parenteral nutrition for both VLBW and ELBW infants. The risk of catheter complications did not increase in ELBW infants. Although the technique of insertion is easy and using PICCs has many benefits, serious and fatal complications may occur in premature neonates in critical states.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23817952     DOI: 10.5301/jva.5000157

Source DB:  PubMed          Journal:  J Vasc Access        ISSN: 1129-7298            Impact factor:   2.283


  6 in total

1.  Effect of implementing an Epicutaneo-Caval Catheter team in Neonatal Intensive Care Unit.

Authors:  Mohammad A A Bayoumi; Matheus F P Van Rens; Prem Chandra; Airene L V Francia; Sunitha D'Souza; Majee George; Saad Shahbal; Einas E Elmalik; Irian J E Cabanillas
Journal:  J Vasc Access       Date:  2020-06-30       Impact factor: 2.283

2.  Prevention of peripherally inserted central line-associated blood stream infections in very low-birth-weight infants by using a central line bundle guideline with a standard checklist: a case control study.

Authors:  Wei Wang; Chunling Zhao; Qinglian Ji; Ying Liu; Guirong Shen; Lili Wei
Journal:  BMC Pediatr       Date:  2015-06-18       Impact factor: 2.125

3.  Application of peripherally inserted central catheters in critically ill newborns experience from a neonatal intensive care unit.

Authors:  Renfeng Li; Xia Cao; Tian Shi; Lei Xiong
Journal:  Medicine (Baltimore)       Date:  2019-08       Impact factor: 1.817

Review 4.  Peripherally inserted central catheters in critically ill patients - complications and its prevention: A review.

Authors:  Sona Duwadi; Qinghua Zhao; Birendra Singh Budal
Journal:  Int J Nurs Sci       Date:  2018-12-21

5.  Vascular injury due to a peripherally inserted central catheter in a neonate born during the 24th week of gestation.

Authors:  Tomonori Kurimoto; Ryo Yonishi; Hirotaka Uehara; Hayato Fukuzato; Satoko Seki; Yoshikazu Shimoji; Okitaka Nakayama; Chiaki Ohba; Iwao Nakazato; Tatsuo Ohshiro
Journal:  Clin Case Rep       Date:  2022-06-19

6.  Ultrasound-guided supraclavicular cannulation of the brachiocephalic vein may reduce central line-associated bloodstream infection in preterm infants.

Authors:  Ignacio Oulego-Erroz; Alba Fernández-García; Beatriz Álvarez-Juan; Sandra Terroba-Seara; Paula Alonso Quintela; Antonio Rodríguez-Núñez
Journal:  Eur J Pediatr       Date:  2020-05-07       Impact factor: 3.860

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.